GlassScriptPhysician profile
Dustin K Devers
NPI 1699989640
$4,191.67
in general payments reported to CMS, 2019-2025
41 companies · $1,218 in 2025
The $1,218 reported for 2025 was more than what 89% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $177 · 2021: $529 · 2022: $421 · 2023: $499 · 2024: $978 · 2025: $1,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,631 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,630.72 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $713.49 | 2021-2025 | Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $424.98 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $352.61 | 2020-2024 | Trelegy Ellipta |
| Lilly USA, LLC | $250.12 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $167.78 | 2019-2024 | Spravato |
| Otsuka America Pharmaceutical, INC. | $159.21 | 2023-2025 | Rexulti |
| Pfizer INC. | $156.32 | 2019-2025 | |
| Teva Pharmaceuticals USA, INC. | $147.43 | 2021-2025 | Austedo Xr, Uzedy |
| Csl Behring | $144.19 | 2024-2025 | Andembry, Haegarda |
| Jazz Pharmaceuticals INC. | $139.56 | 2025 | |
| Abbott Laboratories | $126.36 | 2021-2023 | Freestyle Libre 3 |
| Ironshore Pharmaceuticals INC. | $110.10 | 2021-2024 | |
| Axsome Therapeutics, INC. | $104.54 | 2022-2024 | Auvelity |
| Novartis Pharmaceuticals Corporation | $100.41 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $91.18 | 2021-2024 | Trintellix |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dustin Devers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.